Durability of sotatercept response in pulmonary hypertension: Insights from extended real-world follow-up
Authors:
- Azka NaeemANAzka Naeem
- Olayiwola BolajiOBOlayiwola Bolaji
- George G. KidessGKGeorge G. Kidess
- Joud FahedJFJoud Fahed
- Sultana JahanSJSultana Jahan
- Jawad BasitJBJawad Basit
- Muhammad Hashim KhanMKMuhammad Hashim Khan
- Shaunak MangeshkarSMShaunak Mangeshkar
- Steven SorciSSSteven Sorci
- Hayah Kassis-GeorgeHKHayah Kassis-George
- Sourbha DaniSDSourbha Dani
- M. Chadi AlraiesMAM. Chadi Alraies
- 2 January 2026
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 447, 134150
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Efficacy and safety of sotatercept in pulmonary arterial hypertension: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysisNaunyn-Schmiedeberg's Archives of Pharmacology, 2025
- Global Burden of Pulmonary Arterial Hypertension and Associated Heart FailureJACC: Heart Failure, 2025
- Diagnosis: Pulmonary Hypertension. Next StepsThe American Journal of Medicine, 2025
- Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung TransplantationJHLT Open, 2025
- Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH)Advances in Therapy, 2023
- Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2023
- Sotatercept for the Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2021
- Relative Performance of Propensity Score Matching Strategies for Subgroup AnalysesAmerican Journal of Epidemiology, 2018
- Comparative Effectiveness of Pharmacologic Interventions for Pulmonary Arterial HypertensionChest, 2017
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011